Unexpectedly large CV benefit with icosapent ethyl in statin-treated patients at high CV risk

AHA 2018 - Chicago, IL, USA

3' education - Nov. 20, 2018 - Prof. Erik Stroes, MD

Educational information

This video was recorded at the congress of the American Heart Association on November 10, 2018, in Chicago, IL, USA.

Faculty

Prof. Erik Stroes, MD - Amsterdam UMC, loc. AMC, Amsterdam, The Netherlands

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of the REDUCE-IT results

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.